Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 44,556,000 | 42,879,000 | 42,857,000 | 44,915,000 | 39,211,000 |
| Cost of Goods | 26,318,000 | 25,177,000 | 25,757,000 | 25,944,000 | 19,573,000 |
| Gross Profit | 18,238,000 | 17,702,000 | 17,100,000 | 18,971,000 | 19,638,000 |
| Operating Expenses | 10,491,000 | 10,364,000 | 10,241,000 | 10,578,000 | 9,610,000 |
| Operating Income | 7,746,000 | 7,337,000 | 6,859,000 | 8,393,000 | 10,028,000 |
| Interest Expense | 1,419,000 | 1,390,000 | 1,375,000 | 726,000 | 536,000 |
| Other Income | 940,000 | 1,048,000 | 755,000 | -4,000 | -655,000 |
| Pre-tax Income | 7,267,000 | 6,995,000 | 6,239,000 | 7,663,000 | 8,837,000 |
| Income Tax | 547,000 | 657,000 | 284,000 | 703,000 | 1,109,000 |
| Net Income Continuous | 6,720,000 | 6,338,000 | 5,955,000 | 6,960,000 | 7,728,000 |
| Minority Interests | 17,000 | 3,000 | -40,000 | 10,000 | 3,000 |
| Net Income | $6,704,000 | $6,335,000 | $5,995,000 | $6,950,000 | $7,725,000 |
| EPS Basic Total Ops | 17.77 | 16.58 | 15.52 | 17.75 | 19.62 |
| EPS Basic Continuous Ops | 17.82 | 16.59 | 15.43 | 17.76 | 19.61 |
| EPS Diluted Total Ops | 17.74 | 16.53 | 15.45 | 17.63 | 19.46 |
| EPS Diluted Continuous Ops | 17.78 | 16.55 | 15.35 | 17.67 | 19.47 |
| EPS Diluted Before Non-Recurring Items | 22.87 | 21.86 | 21.55 | 23.24 | 25.13 |
| EBITDA(a) | $10,527,000 | $10,446,000 | $10,265,000 | $11,774,000 | $12,620,000 |